Surface feature-guided mapping of cerebral metabolic changes in cognitively normal and mildly impaired elderly

Molecular Imaging and Biology

Volumn 12, Issue 2, 2010, Pages 218-224

  Apostolova, Liana G ^a   Thompson, Paul M ^a   Rogers, Steve A ^b   Dinov, Ivo D ^a,c   Zoumalan, Charleen ^a   Steiner, Calen A ^a   Siu, Erin ^a   Green, Amity E ^a   Small, Gary W ^a,d   Toga, Arthur W ^a   Cummings, Jeffrey L ^a   Phelps, Michael E ^a   Silverman, Daniel H ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b WESTMONT COLLEGE   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Alzheimer's disease (AD); Cognitive decline; Mild cognitive impairment (MCI); Positron emission tomography (PET)

Indexed keywords

APOLIPOPROTEIN E4; FLUORODEOXYGLUCOSE F 18;

ADULT; AGED; ARTICLE; BRAIN METABOLISM; BRAIN REGION; CINGULATE GYRUS; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FOLLOW UP; FRONTAL CORTEX; GENOTYPE; HUMAN; MALE; MILD COGNITIVE IMPAIRMENT; MINI MENTAL STATE EXAMINATION; NEUROPSYCHOLOGICAL TEST; NUCLEAR MAGNETIC RESONANCE IMAGING; OCCIPITAL LOBE; PARIETAL LOBE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; TEMPORAL LOBE; THREE DIMENSIONAL IMAGING; WECHSLER MEMORY SCALE; WISCONSIN CARD SORTING TEST;

AGED; AGED, 80 AND OVER; BRAIN; BRAIN MAPPING; COGNITION; COGNITION DISORDERS; DEMOGRAPHY; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; MALE; MIDDLE AGED; POSITRON-EMISSION TOMOGRAPHY; SURFACE PROPERTIES;

EID: 77953536045     PISSN: 15361632     EISSN: 18602002     Source Type: Journal    
DOI: 10.1007/s11307-009-0247-7     Document Type: Article

References (35)

1. Monien BH, Apostolova LG, Bitan G (2006) Early diagnostics and therapeutics for Alzheimer's disease - how early can we get there? Expert Rev Neurother 6:1293-1306
2. Apostolova LG, Thompson PM (2007) Brain mapping as a tool to study neurodegeneration. Neurotherapeutics 4:387-400
3. Apostolova LG, Thompson PM (2008) Mapping progressive brain structural changes in early Alzheimer's disease and mild cognitive impairment. Neuropsychologia 46:1597-1612
4. Silverman DHS, Thompson PM (2006) Structural and functional neuroimaging: focussing on mild cognitive impairment. Applied Neurology 10-24
5. Drzezga A, Grimmer T, Riemenschneider M et al (2005) Prediction of individual clinical outcome in MCI by means of genetic assessment and (18)F-FDG-PET. J Nucl Med 46:1625-1632
6. Silverman DH, Small GW, Chang CY et al (2001) Positron emission tomography in evaluation of dementia: regional brain metabolism and long-term outcome. Jama 286:2120-2127
7. Arnaiz E, Jelic V, Almkvist O et al (2001) Impaired cerebral glucose metabolism and cognitive functioning predict deterioration in mild cognitive impairment. NeuroReport 12:851-855
8. Chetelat G, Desgranges B, de la Sayette V et al (2003) Mild cognitive impairment: can FDG-PET predict who is to rapidly convert to Alzheimer's disease? Neurology 60:1374-1377
9. Drzezga A, Lautenschlager N, Siebner H et al (2003) Cerebral metabolic changes accompanying conversion of mild cognitive impairment into Alzheimer's disease: a PET follow-up study. Eur J Nucl Med Mol Imaging 30:1104-1113
10. Mosconi L, Perani D, Sorbi S et al (2004) MCI conversion to dementia and the APOE genotype: a prediction study with FDG-PET. Neurology 63:2332-2340 (Pubitemid 40024346)
11. Mosconi L, Tsui WH, Pupi A et al (2007) (18)F-FDG-PET database of longitudinally confirmed healthy elderly individuals improves detection of mild cognitive impairment and Alzheimer's disease. J Nucl Med 48:1129-1134
12. de Leon MJ, Convit A, Wolf OT et al (2001) Prediction of cognitive decline in normal elderly subjects with 2-[(18)F]fluoro-2-deoxy-D-glucose/ poitron-emission tomography (FDG/PET). Proc Natl Acad Sci U S A 98:10966-10971
13. Buschke H (1984) Cued recall in amnesia. J Clin Exp Neuropsychol 6:433-440
14. Osterrieth PA (1944) Le test de copie d'une figure complexe. Archieves de Psychologie 30:206-356
15. Kelland DZ, Lewis R, Gurevitch D (1992) Evaluation of the Repeatable Cognitive-Perceptual-Motor battery: reliability, validity and sensitivity to diazepam. J Clin Exp Neuropsychol 14:65 abstract
16. Berg L (1948) A simple objective treatment for measuring flexibility in thinking. J Gen Psychol 39:15-22
17. Jensen AR, Rohwer WD (1966) The Stroop Color-Word Test: a review. Acta Psychol 25:36-93
18. Stroop JR (1935) Studies in interference of serial verbal reactions. J Exp Psychol 18:643-662
19. Collins DL, Neelin P, Peters TM et al (1994) Automatic 3-D intersubject registration of MR volumetric data in standardized Talairach space. J Comput Assist Tomogr 18:192-205
20. Shattuck DW, Sandor-Leahy SR, Schaper KA et al (2001) Magnetic resonance image tissue classification using a partial volume model. Neuroimage 13:856-876
21. Shattuck DW, Leahy RM (2002) Brain Suite: an automated cortical surface identification tool. Med Image Anal 6:129-142
22. MacDonald D, Avis D, Evans A (1994) Multiple surface identification and matching in magnetic resonance imaging. Proc SPIE:160-169
23. Hayashi KM, T.P., Mega MS, Zoumalan CI. Medial hemispheric surface gyral pattern delineation in 3-D: surface curve protocol. Available at: http://users.loni.ucla.edu/~khayashi/Public/medial-surface/ [online]. Available.
24. Sowell ER, Thompson PM, Mega MS, Zoumalan CI, Lindshield C, Rex DE. Gyral pattern delineation in 3-D: surface curve protocol. Available at: www.loni.ucla.edu/~esowell/new-sulcvar.html [online]. Available.
25. Thompson PM, Hayashi KM, de Zubicaray G et al (2003) Dynamics of gray matter loss in Alzheimer's disease. J Neurosci 23:994-1005
26. Protas H, Thompson PM, Hayashi KM, et al. (2005) Cortical brain surface mapping for studying partial volume effects in brain FG-PET images. In: 52nd Annual Meeting of the Society for Nuclear Medicine; Toronto, Canada
27. Braskie MN, Klunder AD, Hayashi KM et al (2009) Plaque and tangle imaging and cognition in normal aging and Alzheimer's disease. Neurobiol Aging (in press). doi:10.1016/j.neurobiolaging.2008.09.012
28. Apostolova LG, Steiner CA, Akopyan GG et al (2007) Three-dimensional gray matter atrophy mapping in mild cognitive impairment and mild Alzheimer disease. Arch Neurol 64:1489-1495
29. Mega MS, Dinov ID, Mazziotta JC et al (2005) Automated brain tissue assessment in the elderly and demented population: construction and validation of a sub-volume probabilistic brain atlas. Neuroimage 26:1009-1018
30. Thompson PM, Lee AD, Dutton RA et al (2005) Abnormal cortical complexity and thickness profiles mapped in Williams syndrome. J Neurosci 25:4146-4158
31. Chetelat G, Eustache F, Viader F et al (2005) FDG-PET measurement is more accurate than neuropsychological assessments to predict global cognitive deterioration in patients with mild cognitive impairment. Neurocase 11:14-25
32. Small GW, Ercoli LM, Silverman DH et al (2000) Cerebral metabolic and cognitive decline in persons at genetic risk for Alzheimer's disease. Proc Natl Acad Sci U S A 97:6037-6042
33. Small GW, Mazziotta JC, Collins MT et al (1995) Apolipoprotein E type 4 allele and cerebral glucose metabolism in relatives at risk for familial Alzheimer disease. Jama 273:942-947
34. Reiman EM, Caselli RJ, Yun LS et al (1996) Preclinical evidence of Alzheimer's disease in persons homozygous for the epsilon 4 allele for apolipoprotein E. N Engl J Med 334:752-758
35. Mevel K, Desgranges B, Baron JC et al (2007) Detecting hippocampal hypometabolism in Mild Cognitive Impairment using automatic voxel-based approaches. Neuroimage 37:18-25